Is This the Buyout Novadaq Needs?

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Is This the Buyout Novadaq Needs?

© Thinkstock

Novadaq Technologies Inc. (NASDAQ: NVDQ) watched its shares practically double to kick off the week after the firm announced that it would be acquired by Striker Corp. (NYSE: SYK). The Novadaq board of directors has unanimously approved this deal, but it is still subject to at least a 66% shareholder approval. Considering the premium, this should be a layup.

Under the terms of the agreement, Striker will pay $11.75 per share for all outstanding shares, a premium of 94% from Friday’s closing price of $6.05. At this price, the entire acquisition is valued up to $701 million.

Excluding Monday’s jump, the stock is actually down 15% year to date. Over the past 52 weeks, the numbers get worse and the stock is down over 37%.

However, if we look at the chart at this time in 2014, the stock was over $20 per share. Since this point it’s been a rocky road for the stock, but ultimately shares shifted downward to a multiyear low not seen since 2012.

[nativounit]

Rick Mangat, president and CEO of Novadaq, commented:

This transformative transaction recognizes the exceptional value we have built at NOVADAQ. Moreover, we believe it creates a strong opportunity for NOVADAQ, its customers, partners, shareholders and employees. I am proud of the impact our SPY and PINPOINT technology has made throughout the world in breast reconstruction and colorectal surgery, as well as other minimally invasive applications, and look forward to the additional progress we can make as part of Stryker’s organization.

Shares of Novadaq were trading up about 95% at $11.65 on Monday, with a consensus analyst price target of $11.03 and a 52-week range of $5.84 to $12.74.

Stryker shares traded at $142.67. The stock has a 52-week range of $106.48 to $145.62.

[wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618